Baiyunshan and Baxter plan to form Parenteral Nutrition Joint Venture in China
Advertisement
Baxter International Inc. and Guangzhou Baiyunshan Pharmaceutical Co. Ltd. announced plans to establish a joint venture to produce and sell parenteral nutrition products in China. Under the terms of a framework agreement, subsidiaries of the two companies will form a 50/50 joint venture during the first half of 2007. The companies expect to invest between (US)$65 and $70 million over the life of the joint venture. The agreement is subject to government review and approval.
To establish the new business, Guangzhou Baiyunshan Pharmaceutical will contribute its existing parenteral nutrition business and assets located in Guangzhou, China, through one of its subsidiaries, Baiyunshan Qiaoguang Pharmaceutical Co., Ltd. Baxter will help fund the venture and strengthen its product line, and manufacturing, clinical, and marketing expertise. The new business will manufacture and sell current Qiaoguang parenteral nutrition products and gradually expand its portfolio to include Baxter's products.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Constab Polyolefin Additives GmbH - Rüthen, Germany
Metrohm Nordic Oy - Espoo, Finland
Süd-Chemie and LG Chem to jointly manufacture high quality LFP
The quantum secret to alcohol reactions in space
Sometimes less is more - RUB researchers unmask Janus-faced nature of mechanical forces with the Jülich supercomputer
With Terlux from BASF: Greater transparency in medicine
BOC expands distributor network - Signs Merriam-Graves, New Hampshire-based compressed gas distributor
Even low concentrations of silver can foil wastewater treatment
As tellurium demands rise, so do contamination concerns
The Chemistry of Paper and Polymer Banknotes
